The downregulation of ST6GAL1 decreased metalloproteinases (MMPs) expression and suppressed invasive potential of A549 and H1299 cells in vitro [79], whereas bladder cancer has ST6GAL1 upregulation, a tumor-suppressive role [81]. The gene discussed is ST6GAL1; the disease is urinary bladder carcinoma.